Significance of Biomarker Panel Including Cardiac Troponin I, D-dimer, and B-Type Natriuretic Peptide in Acute Aortic Dissection

Authors

  • Carlos Jerjes-Sanchez Instituto de Cardiología y Medicina Vascular,TEC Salud y Escuela de Medicina y Ciencias de la Salud del Sistema Tecnológico de Monterrey and Director of Unidad de Investigacion Clinica en Medicina SC, Mexico
  • Nualik Garcia Hospital de Cardiologia No 34, IMSS, Monterrey, NL, Mexico
  • Enrique Diaz de Leon-Gonzalez Hospital de Especialidades No. 25, IMSS, Monterrey, NL, Mexico
  • Anabel Garcia-Sosa Emergency Care Department, Hospital de Cardiologia No 34, IMSS, Monterrey, NL, Mexico
  • Carlos Jerjes Sanchez Ramirez Escuela de Medicina y Ciencias de la Salud del Sistema Tecnológico de Monterrey, Nuevo León, Mexico

DOI:

https://doi.org/10.12970/2311-052X.2013.01.02.4

Keywords:

 Acute aortic dissection, B-type natriuretic peptide, D-dimer, cardiac troponin I, risk stratification.

Abstract

We assessed whether elevated serum cardiac troponin I (cTnI), D-dimer and B-type natriuretic peptide were associated with short-term mortality in patients with acute aortic dissection (AAD).From 2010 to 2011, 6455 consecutive patients with acute chest pain were admitted to our emergency department, 15 (0.23%) of whom had AAD diagnosed and biomarker data collected. AAD was confirmed on transthoracic esophageal echocardiogram and computed tomography. Patients with abnormal cTnI concentrations had a higher rate of mortality. In univariate analysis, elevated cTnl was an independent predictor of in-hospital mortality (relative risk 27.46, 95% confidence interval 1.20–629.31). No relationship between mortality and D-dimer, B-type natriuretic peptide or the DeBakeyclassifications was identified. In conclusion, elevated serum cTnI identifiesAAD patients at high risk of in-hospital mortality. These findings suggest that cTnl may be a promising tool for rapid risk stratification of patients with AAD.

References

Nienaber CA, Powell JT. Management of acute aortic syndromes. Eur Heart J 2012; 33: 26-35b. http://dx.doi.org/10.1093/eurheartj/ehr186

Ohlmann P, Faure A, Morel O, et al. Diagnostic and prognostic value of circulating D-Dimers in patients with acute aortic dissection. Crit Care Med 2006; 34: 1358-64. http://dx.doi.org/10.1097/01.CCM.0000216686.72457.EC

Elefteriades JA, Farkas EA.Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol 2010; 55: 841-57. http://dx.doi.org/10.1016/j.jacc.2009.08.084

Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation 2003; 108: 628-35. http://dx.doi.org/10.1161/01.CIR.0000087009.16755.E4

Erbel R, Alfonso F, Boileau C, et al. Diagnosis and management of aortic dissection. Eur Heart J 2001; 22: 1642-81. http://dx.doi.org/10.1053/euhj.2001.2782

Eggers KM, Lagerqvist B, Oldgren J, Venge P, Wallentin L, Lindahal B. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Am Heart J 2008; 156: 588-94. http://dx.doi.org/10.1016/j.ahj.2008.04.022

Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012; 33: 579-86. http://dx.doi.org/10.1093/eurheartj/ehr492

Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011; 32: 404-11. http://dx.doi.org/10.1093/eurheartj/ehq456

Bonnefoy E, Godon P, Kirkorian G, Chabaud S, Touboul P. Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta. Acta Cardiol 2005; 60: 165-70. http://dx.doi.org/10.2143/AC.60.2.2005027

Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48: 1-11. http://dx.doi.org/10.1016/j.jacc.2006.02.056

Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357-68. http://dx.doi.org/10.1016/j.jacc.2007.09.021

Yanez J, Rodriguez D, Trevino C, Valdez A, Jerjes-Sanchez C. Stress transient hypertrophic cardiomyopathy and B-type natriuretic peptide role. Pediatr Cardiol 2013; 34: 702-6. http://dx.doi.org/10.1007/s00246-012-0317-5

Ranasinghe AM, Bonser RS. Biomarkers in acute aortic dissection and other aortic syndromes. J Am Coll Cardiol 2010; 56: 1535-41. http://dx.doi.org/10.1016/j.jacc.2010.01.076

Sbarouni E, Georgiadou P, Marathias A, Geroulanos S, Kremastinos DT. D-dimer and BNP levels in acute aortic dissection. Int J Cardiol 2007; 122: 170-2. http://dx.doi.org/10.1016/j.ijcard.2006.11.056

Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011; 32: 670-9. http://dx.doi.org/10.1093/eurheartj/ehq426

Weber T, Hogler S, Auer J, et al. D-dimer in acute aortic dissection. Chest 2003; 123: 1375-8. http://dx.doi.org/10.1378/chest.123.5.1375

Downloads

Published

2013-07-02

Issue

Section

Articles